Genexpath specializes in designing and marketing next-generation diagnostic tests to characterize cancers such as non-Hodgkin's lymphomas and sarcomas. These innovative products result from cutting-edge academic research and integrate molecular biology, artificial intelligence, and bioinformatics to advance cancer understanding and treatment efficacy. Since its inception, Genexpath has focused on making its products accessible for diagnostic use in molecular biology laboratories and anatomopathology departments, offering comprehensive, turnkey solutions from benchside processes to bioinformatics data analysis.

Learn More :   

Website : www.genexpath.com